KF/Al2O3: SOLID-SUPPORTED REAGENT
3267
J ¼ 8.9 and 1.2 Hz, Ar), 7.29–7.41 (5H, m, Ph), and 7.63 (2H, dd, J ¼ 8.9 and 1.2 Hz,
Ar); 13C NMR (CDCl3) d 43.44 (C-4), 55.35 (MeO), 82.29 (C-5), 114.14, 122.04,
125.87, 128.14, 128.27, 128.72, 141.09 (Ph and Ar), 155.66 (C-3), and 161.09 (Ar);
MS (m=z): 254 (Mþ1, base peak), 253 (73, Mþ), 221 (13), 207 (12), 154 (17), 147
(40), 136 (20), and 73 (24). Anal. found: C, 75.78; H, 6.03; N, 5.46. Calculated for
C16H15NO2: C, 75.87; H, 5.96; N, 5.53.
3-Benzyl-5-phenyl-2-isoxazoline (3i). Colorless oil; IR (neat) 3040, 2920,
1
1610, 1500, 1460, 1430, 1080, 1040, 760, and 700 cmꢂ1; H NMR (CDCl3) d 2.75
(1H, dd, Jgem ¼ 17.1 Hz and J4–5 ¼ 8.4 Hz, one of H-4), 3.18 (1H, dd, Jgem ¼ 17.1 Hz
and J4–5 ¼ 10.9 Hz, the other of H-4), 3.64 (1H, d, Jgem ¼ 14.8 Hz, one of PhCH2),
3.71 (1H, d, Jgem ¼ 14.8 Hz, the other of PhCH2), 5.47 (1H, dd, J5–4 ¼ 8.4 and
10.9 Hz, H-5), and 7.20–7.30 (10H, m, Ph); 13C NMR (CDCl3) d 33.91 (PhCH2),
44.27 (C-4), 81.61 (C-5), 125.56, 126.92, 127.82, 128.44, 128.64, 135.47, 140.84 (each
Ph), and 157.23 (C-3); MS m=z (rel. intensity, %) 238 (Mþ1, base peak), 107 (6), 91
(16), and 77 (4). Anal. found: C, 80.67; H, 6.41; N, 5.85. Calcd. for C16H15NO: C,
80.98; H, 6.37; N, 5.90.
5-Phenyl-3-propyl-2-isoxazoline (3j). Light yellow oil; 1H NMR (CDCl3) d
0.97 (3H, t, J ¼ 7.5 Hz, CH3 of n-Pr), 1.62 (2H, tt, J ¼ 7.5 and 7.5 Hz, CH2 of n-Pr),
2.36 (2H, t, J ¼ 7.5 Hz, CH2 of n-Pr), 2.89 (1H, dd, Jgem ¼ 16.9 Hz and J4–5 ¼ 8.2 Hz,
one of H-4), 3.35 (1H, dd, Jgem ¼ 16.9 Hz and J4–5 ¼ 10.9 Hz, the other of H-4), 5.54
(1H, dd, J5–4 ¼ 10.9 and 8.2 Hz, H-5), 7.29–7.38 (5H, m, Ph); 13C NMR (CDCl3) d
13.71, 19.76, 29.57 (each n-Pr), 45.30 (C-4), 81.16 (C-5), 125.67, 127.94, 128.63,
141.37 (each Ph), and 158.34 (C-3); MS m=z (rel. intensity, %) 189 (Mþ1, 55), 161
(21), 117 (18), 104 (base peak), 91 (17), and 77 (20). Anal. found: C, 75.89; H,
8.00; N, 7.39. Calcd. for C12H15NO: C, 76.16; H, 7.99; N, 7.40.
5-Phenyl-3-isopropyl-2-isoxazoline (3k). Light yellow oil; 1H NMR
(CDCl3) d 1.18 (3H, d, J ¼ 7.0 Hz, one of Me), 1.19 (3H, d, J ¼ 7.0 Hz, the other
of Me), 2.75 (1H, sep, J ¼ 7.0 Hz, Me2CH), 2.94 (1H, dd, Jgem ¼ 16.9 Hz and J4–5
¼
8.2 Hz, one of H-4), 3.63 (1H, dd, Jgem ¼ 16.9 Hz and J4–5 ¼ 10.9 Hz, the other of
H-4), 5.53 (1H, dd, J5–4 ¼ 10.9 and 8.2 Hz, H-5), and 7.27–7.38 (5H, m, Ph); 13C
NMR (CDCl3) d 20.08, 20.09, 27.89 (each i-Pr), 43.24 (C-4), 81.24 (C-5), 125.67,
127.93, 128.62, 141.39 (each Ph), and 162.98 (C-3); MS m=z (rel. intensity, %) 189
(Mþ1, 58), 117 (18), 104 (base peak), and 77 (21). Anal. found: C, 75.91; H, 7.98;
N, 7.45. Calcd. for C12H15NO: C, 76.16; H, 7.99; N. 7.40.
5-Phenyl-3-(4-pyridyl)-2-isoxazoline (3l). Colorless plates from CH2Cl2–
hexane; mp 67–698ꢁ C; IR (KBr) 3000, 2200, 1590, 1400, 1350, 900, 810, 720, and
1
690 cmꢂ1; H NMR (CDCl3) d 3.32 (1H, dd, Jgem ¼ 16.7 Hz and J4–5 ¼ 8.5 Hz, one
of H-4), 3.76 (1H, dd, Jgem ¼ 16.7 Hz and J4–5 ¼ 11.1 Hz, the other of H-4), 5.81
(1H, dd, J5–4 ¼ 11.1 and 8.5 Hz, H-5), 7.32–7.42 (5H, m, Ph), 7.54 (2H, dd, J ¼ 4.5
and 1.7 Hz, Ar), and 8.68 (2H, dd, J ¼ 4.5 and 1.7 Hz, Ar); 13C NMR (CDCl3) d
42.11 (C-4), 83.46 (C-5), 120.88, 125.81, 128.52, 128.88, 136.77, 140.19, 150.46 (Ph
and Ar), and 154.59 (C-3); MS m=z (rel. intensity, %) 224 (Mþ1, 58) and 104 (base
peak). Anal. found: C, 74.98; H, 5.42; N, 12.44. Calcd. for C14H12N2O: C, 74.98;
H, 5.39; N, 12.49.